Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Whisper Number: What Will Amgen’s Shares Do Post-Earnings?
Wall St. Cheat Sheet
Tuesday, October 22, 2013 - 11:24am
tags:
Amgen, earnings
J&J-Medivir’s Drug Works Against Hepatitis C
Bloomberg
Tuesday, October 22, 2013 - 8:36am
tags:
JNJ, Medivir, hepatitis C, simeprevir, FDA
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study
TheStreet.com
Tuesday, October 22, 2013 - 8:30am
tags:
Insmed, Arikace, cystic fibrosis
Forest quarterly earnings beat analyst expectations
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:17am
tags:
earnings, Forest Labs
Evotec, AstraZeneca in Kidney Disease Alliance
Contract Pharma
Tuesday, October 22, 2013 - 8:16am
tags:
kidney disease, AstraZeneca, Evotec
Roche's Avastin boosts survival in advanced ovarian cancer
Pharma Times, UK
Tuesday, October 22, 2013 - 8:15am
tags:
Roche, ovarian cancer, Avastin
Lilly's Pipeline Fears Are Overblown
TheStreet.com
Tuesday, October 22, 2013 - 8:14am
tags:
Eli Lilly, Merck, Pfizer, patent cliff
Novartis Raises 2013 Forecast on Lack of Diovan Generic
Bloomberg
Tuesday, October 22, 2013 - 8:11am
tags:
Novartis, guidance, Diovan
Health-Care False Claims Cases Reap $18.3 Billion, Report
Bloomberg
Tuesday, October 22, 2013 - 8:10am
tags:
whistleblower lawsuits, False Claims Act
Illumina reports eighth beat in a row, raises profit forecast
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:08am
tags:
earnings, Illumina
Medivation, Astellas prostate cancer drug meets trial goals
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:07am
tags:
Medivation, prostate cancer, Astellas, Enzalutamide
Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Monday, October 21, 2013 - 5:55pm
tags:
Novartis, cyclin-dependent kinase inhibition [CDK], Pfizer, palbociclib, LEE011
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Yahoo
Monday, October 21, 2013 - 5:51pm
tags:
diabetes, Depomed, PDL Biopharma
Will Celgene's (CELG) Earnings Streak End?
Yahoo/Zacks
Monday, October 21, 2013 - 5:50pm
tags:
Celgene, earnings
Ending drug trial secrecy is a boon for R&D, says EU agency
Yahoo/Reuters
Monday, October 21, 2013 - 5:49pm
tags:
clinical trial data, R&D
Is Amarin Going Belly-Up?
Seeking Alpha
Monday, October 21, 2013 - 4:16pm
tags:
Amarin, FDA, Vascepa
OncoMed presents data from trials of four anti-CSC therapeutics
The Fly on the Wall
Monday, October 21, 2013 - 4:14pm
tags:
OncoMed, anti-CSC
3 Red Flags for This Biotech IPO
Motley Fool
Monday, October 21, 2013 - 4:13pm
tags:
Intrexon, IPOs
Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Fierce Biotech
Monday, October 21, 2013 - 11:55am
tags:
John Lechleiter, R&D, Eli Lilly
Earnings for C.R. Bard Expected to Fall
Forbes
Monday, October 21, 2013 - 11:54am
tags:
CR Bard, earnings, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.